What is the potential of combination therapies, including antibiotics and non-antibiotic agents, for treating Pseudomonas aeruginosa infections?

... infection with pseudomonas aeruginosa in neurosurgery. Lancet, 1965, 2:365–368.Ayliffe, G. A. J., Lowbury, E. J. L., Hamilton, J. G., Small, J. M., Asheshov ... What is Pseudomonas aeruginosa? Pseudomonas aeruginosa (PsA) is a type of bacteria (germ) that is commonly found in soil and water, and likely to live in ... Sep 7, 2000 ... We conducted an epidemiologic and molecular investigation of endemic P. aeruginosa infection among infants in a neonatal intensive care unit. Clinical Signs. P. aeruginosa infections typically are contracted from heavily infested surfaces such as tubing or water tubs, and virtually any animal can ... Pseudomonas Aeruginosa Infection. A Pseudomonas aeruginosa infection is a condition that can affect your skin, blood, lungs, GI tract and other parts of your ... Some P. aeruginosa are becoming more resistant to even antibiotics of last resort, and are described as multidrug-resistant. Abstract. Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen and a model bacterium for studying virulence and bacterial social traits. While it ... Some types of Pseudomonas have developed resistance to carbapenems, and these bacteria are called carbapenem-resistant Pseudomonas aeruginosa (CRPA). Pseudomonas aeruginosa infections are the predominant driver of CF lung disease, and airway isolates are frequently resistant to multiple antimicrobials ... abstract. The wbp gene cluster, encoding the B-band lipopolysaccharide O antigen of Pseudomonas aeruginosa serotype O5 strain PAO1, was previously shown to ...